A Recurrence Nomogram for Hepatoid Adenocarcinoma of the Stomach

Fujian Medical University261 enrolled

Overview

This study aims to develop a nomogram to predict postoperative recurrence of HAS and guide individually tailored surveillance strategies.

Patients were included from the China Hepatoid Adenocarcinoma of the Stomach Study Group (China-HASSG) database, which comprises 14 tertiary referral centers. All the patients who had undergone complete resection of a primary HAS between April 2004 and December 2019 were included. First, univariate analysis was performed in Cox regression to identify the risk factors associated with RFS. Next, variables with P\< 0.05 in univariable analysis were included in the multivariable model, and the forward likelihood ratio method was used for analysis to confirm the independent prognostic factors associated with RFS. Finally, based on the results of multivariable analysis, variables that achieved significance at P\< 0.05 were selected to formulate a nomogram.

Study Type

OBSERVATIONAL

Enrollment

261

Conditions

Gastric Cancer

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who had undergone complete resection of a primary HAS between April 2004 and December 2019 Exclusion Criteria: * Patients with metastatic disease, patients who had undergone palliative surgery, patients who had died within 30 days, and patients who were lost to follow-up

Locations (1)

Fujian Medical University Union Hospital

Fuzhou, Fujian, China

Outcomes

Primary Outcomes

Reurrence-free survival

Reurrence-free survival was defined as the time interval from the date of the operation to the date of first recurrence or death from any cause.

Time frame: 3 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.